| S.No | Product | Status |
|---|---|---|
| 1 | Vildagliptin | Commercialised |
| 2 | Tapentadol Hydrochloride | Commercialised |
| 3 | Tadalafil | Commercialised |
| 4 | Rivaroxaban | Commercialised |
| 5 | Obeticholic acid | Development Completed |
| 6 | Brivaracetam | Development Completed |
| 7 | Remogiflozin Etabonate | Development Completed |
| 8 | Obeticholic acid | Development Completed |
| 9 | Empagliflozin | Development Completed |
| 10 | Canagliflozin | Development Completed |
| 11 | Safinamide | U/Development |
| 12 | Ferric Carboxy maltose | U/Development |
| 13 | Bilastine | U/Development |
| 14 | Bempedoic acid | U/Development |
| 15 | Sarecycline | U/Development |
Note :- Some of the products may have patent rights in one or more countries and any such product having an existing patent will not be offered/sold for commercial requirements. The final responsibility with respect to third party patent rights lies exclusively with the buyer.